Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T21:33:33.414Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:33:33.414Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 63,777,806
TTM operating cash flow · period ending 2026-06-30: -70,895,000

FMP input reference: e1640542559587d997c0d8eaeaaf8c892bebef217736e9d4e66575bab6404537

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

PLRX Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

PRICE/OCF RATIO AVG TTM

N/A

PRICE/OCF RATIO AVG 3Y

N/A

PRICE/OCF RATIO AVG 5Y

N/A

PRICE/OCF RATIO AVG 10Y

N/A

PRICE/OCF RATIO AVG 15Y

N/A

PRICE/OCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PLRX Competitors' Price/OCF Ratio

PLRX

Pliant Therapeutics, Inc.

Current

Market Cap

$63.78M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALPS

Alps Group Inc

vs PLRX

Market Cap

$64.18M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs PLRX

Market Cap

$63.02M

Price/OCF Ratio

6.69

TTM Avg

5.29

3Y Avg

5.29

5Y Avg

30.61

HRTX

Heron Therapeutics, Inc.

vs PLRX

Market Cap

$62.78M

Price/OCF Ratio

N/A

TTM Avg

1.86

3Y Avg

1.86

5Y Avg

1.86

RNXT

RenovoRx, Inc.

vs PLRX

Market Cap

$62.62M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XBIT

XBiotech Inc.

vs PLRX

Market Cap

$65.85M

Price/OCF Ratio

N/A

TTM Avg

4.25

3Y Avg

4.25

5Y Avg

4.25

CING

Cingulate Inc.

vs PLRX

Market Cap

$65.86M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOSS

Gossamer Bio, Inc.

vs PLRX

Market Cap

$65.87M

Price/OCF Ratio

N/A

TTM Avg

35.67

3Y Avg

35.67

5Y Avg

35.67

GUTS

Fractyl Health, Inc.

vs PLRX

Market Cap

$60.42M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IBIO

iBio, Inc.

vs PLRX

Market Cap

$67.52M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Pliant Therapeutics, Inc. (PLRX)	$63.78M	N/A	N/A	N/A	N/A
Alps Group Inc (ALPS)vs ›	$64.18M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.02M	6.69	5.29	5.29	30.61
Heron Therapeutics, Inc. (HRTX)vs ›	$62.78M	N/A	1.86	1.86	1.86
RenovoRx, Inc. (RNXT)vs ›	$62.62M	N/A	N/A	N/A	N/A
XBiotech Inc. (XBIT)vs ›	$65.85M	N/A	4.25	4.25	4.25
Cingulate Inc. (CING)vs ›	$65.86M	N/A	N/A	N/A	N/A
Gossamer Bio, Inc. (GOSS)vs ›	$65.87M	N/A	35.67	35.67	35.67
Fractyl Health, Inc. (GUTS)vs ›	$60.42M	N/A	N/A	N/A	N/A
iBio, Inc. (IBIO)vs ›	$67.52M	N/A	N/A	N/A	N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PLRX Price/OCF Ratio History

DATE	PRICE/OCF RATIO
2021-03-16	85.52
2021-03-15	84.92
2021-03-12	84.54
2021-03-11	84.96
2021-03-10	84.74
2021-03-09	84.67
2021-03-08	76.30
2021-03-05	69.99
2021-03-04	71.39
2021-03-03	79.96
2021-03-02	81.69
2021-03-01	78.79
2021-02-26	73.50
2021-02-25	88.27
2021-02-24	88.98
2021-02-23	75.81
2021-02-22	77.65
2021-02-19	73.65
2021-02-18	67.46
2021-02-17	71.01
2021-02-16	73.08
2021-02-12	69.57
2021-02-11	66.35
2021-02-10	64.26
2021-02-09	71.32
2021-02-08	69.63
2021-02-05	75.74
2021-02-04	69.54
2021-02-03	68.35
2021-02-02	68.17
2021-02-01	56.22
2021-01-29	54.66
2021-01-28	55.71
2021-01-27	58.08
2021-01-26	60.10
2021-01-25	60.53
2021-01-22	58.86
2021-01-21	57.93
2021-01-20	56.53
2021-01-19	58.37
2021-01-15	58.04
2021-01-14	57.48
2021-01-13	61.53
2021-01-12	61.55
2021-01-11	60.99
2021-01-08	60.93
2021-01-07	61.37
2021-01-06	60.79
2021-01-05	55.40
2021-01-04	54.46
2020-12-31	50.47
2020-12-30	51.82
2020-12-29	54.84
2020-12-28	55.88
2020-12-24	56.44
2020-12-23	56.95
2020-12-22	58.26
2020-12-21	56.51
2020-12-18	56.62
2020-12-17	59.93
2020-12-16	61.28
2020-12-15	63.95
2020-12-14	60.90
2020-12-11	59.17
2020-12-10	60.62
2020-12-09	58.28
2020-12-08	61.44
2020-12-07	60.37
2020-12-04	62.64
2020-12-03	62.77
2020-12-02	63.30
2020-12-01	66.64
2020-11-30	61.13
2020-11-27	73.28
2020-11-25	66.12
2020-11-24	65.37
2020-11-23	64.08
2020-11-20	63.57
2020-11-19	60.79
2020-11-18	58.37
2020-11-17	64.35
2020-11-16	58.33
2020-11-13	55.00
2020-11-12	57.11
2020-11-11	56.06
2020-11-10	17.12
2020-11-09	16.35
2020-11-06	15.86
2020-11-05	16.38
2020-11-04	15.89
2020-11-03	15.53
2020-11-02	15.37
2020-10-30	15.70
2020-10-29	15.64
2020-10-28	15.11
2020-10-27	16.09
2020-10-26	16.50
2020-10-23	17.26
2020-10-22	16.75
2020-10-21	16.60
2020-10-20	16.56
2020-10-19	17.62
2020-10-16	18.05
2020-10-15	17.61
2020-10-14	17.11
2020-10-13	17.81
2020-10-12	18.06
2020-10-09	17.66
2020-10-08	17.12
2020-10-07	17.68
2020-10-06	15.92
2020-10-05	15.56
2020-10-02	14.59
2020-10-01	14.44
2020-09-30	16.45
2020-09-29	17.24
2020-09-28	16.37
2020-09-25	15.64
2020-09-24	16.28
2020-09-23	16.03
2020-09-22	17.08
2020-09-21	17.35
2020-09-18	20.49
2020-09-17	20.06
2020-09-16	19.94
2020-09-15	18.87
2020-09-14	19.96
2020-09-11	19.04
2020-09-10	19.04
2020-09-09	18.08
2020-09-08	17.57
2020-09-04	16.91
2020-09-03	17.65
2020-09-02	17.80
2020-09-01	18.16
2020-08-31	18.26
2020-08-28	18.87
2020-08-27	17.72
2020-08-26	17.84
2020-08-25	17.76
2020-08-24	17.76
2020-08-21	18.29
2020-08-20	18.44
2020-08-19	17.86
2020-08-18	17.89
2020-08-17	17.98
2020-08-14	17.70
2020-08-13	17.79
2020-08-12	17.64

Price/OCF Ratio: N/A

PLRX Price/OCF Ratio Chart

PLRX Price/OCF Ratio Metrics

PLRX Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

PLRX Price/OCF Ratio History

Related Metrics